semaglutide and thyroid cancer risk Ozempic is facing a $2 billion lawsuit the headline is actually the least of Novo Nordisk's problems. Over 3,500 people have filed claims in federal court. The cases getting Ozempic Safety Debate Continues!! Ozempic

Beyond the scale, GLP-1 treatments support heart health, improve insulin sensitivity, and reduce risks linked to obesity

GLP-1related hair loss is usually reversible

If you're using the same site repeatedly, space injections at least one inch apart and avoid areas where you see lumps, dimples, or skin thickening

184 Just as intriguing, GLP-1R-mediated signaling properties of ago-allosteric modulators are not identical, thereby suggesting that such agonists could be used in order to achieve signal transduction bias

Medical Considerations Low IGF-1 with symptoms of GH deficiency may warrant: GH stimulation testing Consideration of GH or peptide therapy under endocrinology or functional medicine guidance High IGF-1 may require: Acromegaly screening (IGF-1 + oral glucose tolerance GH suppression test) Adjustment of therapy dosages Cancer risk assessment and monitoring IGF-1, Longevity, and Health Span The relationship between IGF-1 and lifespan is U-shaped both extremes are associated with higher risk